|
2022
|
Invention
|
Pharmaceutical salts of a chk-1 inhibitor. The invention provides a pharmaceutically acceptable s... |
|
|
Invention
|
Preparation of a chk1 inhibitor compound. The invention provides a novel synthetic route for the ... |
|
2021
|
Invention
|
Pyrrole derivatives as plk1 inhibitors. The invention provides compounds of the formula (3):
4.
... |
|
|
Invention
|
A pharmaceutical salt of an arylpyrrole derivative.
The present invention relates to (R)-4-[5-(4... |
|
|
Invention
|
A pharmaceutical salt of an arylpyrrole derivative. The present invention relates to (/?)-4-[5-(4... |
|
|
Invention
|
Pharmaceutical compounds. This invention relates to compounds that inhibit or modulate the activi... |
|
2020
|
Invention
|
Pyrrolo[2,3-d]pyrimidine derivatives and their use in the treatment of cancer. The invention prov... |
|
|
Invention
|
Pharmaceutical compounds.
The invention provides a composition of matter which:
The invention ... |
|
|
Invention
|
Pharmaceutical compounds. The invention provides a composition of matter which: ? (i) consists of... |
|
|
Invention
|
Pharmaceutical compounds. The invention provides a composition of matter which: • (i) consists of... |
|
2019
|
Invention
|
2-aminoquinazoline derivatives as p70s6 kinase inhibitors. The invention provides compound that i... |
|
2018
|
Invention
|
Pyrrole derivatives as plk1 inhibitors. The invention provides compounds of the formula (3): or a... |
|
2017
|
Invention
|
Pharmaceutically active pyrazine derivatives.
The invention provides compounds which inhibit or ... |
|
2016
|
Invention
|
Substituted quinoxalines and benzotriazine p70s6 kinase inhibitors. The invention provides compou... |
|
|
Invention
|
Modulators of the p70s6 kinase for use in the treatment of brain disorders and triple-negative br... |
|
2015
|
Invention
|
Pyrazole compounds as chk1 inhibitors for the treatment of cancer. This invention relates to pyra... |
|
2012
|
Invention
|
Pharmaceutically active pyrazine derivatives. The invention provides compounds which inhibit or m... |
|
2011
|
Invention
|
Pharmaceutical compounds. A compound of the formula (I):
|
|
|
Invention
|
Modulators of chk-1 activity. The invention provides a compound of the formula (1): or a salt, N-... |
|
2010
|
Invention
|
Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase. The invention provides... |
|
2009
|
Invention
|
Pharmaceutical compounds. The invention provides kinase inhibitor compounds of the formula (1):
... |
|
|
Invention
|
Pharmaceutical compounds. The invention provides kinase inhibitor compounds of the formula (1): o... |
|
2008
|
Invention
|
N-oxide-containing pharmaceutical compounds. The invention provides a method of preparing a thera... |
|
2007
|
Invention
|
Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core. The invention provides comp... |
|
|
Invention
|
Quinoline and quinoxaline n-oxides as chk-1 inhibitors. The invention provides compounds of the f... |
|
|
Invention
|
Pharmaceutical compounds. The invention provides a compound of the formula (1) or a salt, solvate... |
|
|
Invention
|
N-oxides of diarylurea derivatives and their use as chk1 inhibitors for the treatment of cancer. ... |
|
2006
|
Invention
|
Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors.
The invention relates to n... |
|
|
Invention
|
Heterocyclic triazines as hypoxic selective protein kinase inhibitors. The invention relates to n... |
|
|
Invention
|
Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors. The invention relates to no... |
